N/A
N=18
Resiliency Among Older Adults Receiving Lung Cancer Treatment
Advanced Lung Carcinoma · Extensive Stage Lung Small Cell Carcinoma · Stage IIIA Lung Cancer AJCC v8 · Stage IIIB Lung Cancer AJCC v8 · Stage IV Lung Cancer AJCC v8
Bottom Line
View on ClinicalTrials.gov: NCT04229381 ↗Enrolled (actual)
18
Serious AEs
0.0%
Results posted
Nov 2023
Primary outcome: Primary: Recruitment Rates — 11 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Physical Therapy (Procedure); Quality-of-Life Assessment (Other); Questionnaire Administration (Other); Relaxation Therapy (Procedure)
- Age
- Adult, Older Adult · 60+ yrs
- Sex
- All
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Primary completion
- Jun 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Recruitment Rates |
11 | — |
| PRIMARY Adherence Rate |
11 | — |
| PRIMARY Retention Rates |
16 | — |
| SECONDARY Functional Trajectories |
— | — |
| SECONDARY Factors Associated With Resiliency |
— | — |
Summary
This trial studies how well physical therapy and progressive muscle relaxation works in improving physical performance and mood in older patients with stage IIIA-B or IV lung cancer who are undergoing treatment. Improving physical performance and mood may help older patients maintain an independent lifestyle by helping to improve their resilience, the ability to bounce back to normal functioning after a stressor or intervening health event such as treatment or disease progression. Giving physical therapy and progressive muscle relaxation may work in improving symptoms and quality of life in patients with lung cancer.
Eligibility Criteria
Inclusion Criteria
- Diagnosed with advanced lung cancer: unresectable stage IIIA, IIIB, or stage IV non-small cell lung cancer (NSCLC) or extensive stage small cell lung cancer (SCLC).
- Intent to receive treatment from the Ohio State University Comprehensive Cancer Center (OSUCCC) Thoracic Oncology Clinic.
- Willingness to participate and adhere to the study intervention program.
- Ability to understand and willingness to sign an informed consent document (or indicate approval or disapproval by another means).
Exclusion Criteria
- Prisoners are excluded from participation.
- There is NO exclusion criteria pertaining to Eastern Cooperative Oncology Group (ECOG) performance status, laboratory values, prior cancer diagnoses, presence of comorbidities or brain metastases.
Data sourced from ClinicalTrials.gov (NCT04229381). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.